First real-world, nationwide evidence that an opt-out, mailed #SelfSampling strategy can substantially improve #CervicalCancer screening coverage.
In the Netherlands, participation increased from 42.1% to 49.9% (RR 1.19, 95% CI 1.18–1.19).
www.thelancet.com/journals/lan...